Latest Articles
A Third Of Americans Show Signs Of Clinical Anxiety Or Depression, Census Data Indicate
Healio (5/29) reported that on May 28, the FDA “announced the approval of Tauvid [flortaucipir F18], an IV injection that is used to help image a specific characteristic of Alzheimer’s disease in the brain known as tau pathology.” The agency has approved Tauvid for “adults who have cognitive impairment and are being evaluated for Alzheimer’s disease, according to an FDA press release.” Tauvid “is a radioactive diagnostic agent that is indicated for positron emission tomography imaging of the brain” that is “used to assess the density and distribution of aggregated tau neurofibrillary tangles…which is a primary signal of Alzheimer’s disease, the release said.”
FDA Approves Flortaucipir F18 To Help Detect Tau Pathology, A Specific Characteristic Of Alzheimer’s
Low-Dose Aspirin Does Not Prevent Depression Among Older Adults, Research Indicates
Esketamine Nasal Spray May Rapidly Reduce Depressive Symptoms Among Severely Ill Patients With MDD Who Have Active Suicidal Ideation With Intent, Study Suggests
Weekly Sessions Of Yoga May Ease Depressive Symptoms In People With Other Mental Health Issues, Research Suggests
Preventing Heart Disease May Be Protective Against Cognitive Decline, Researchers Say
Study Suggests Delirium, Agitation May Follow COVID-19 Infection
Stresses On Older People, Their Caregivers Associated With COVID-19 May Increase Risk Of Elder Abuse, Experts Say
Dementia, Visual Impairment Can Both Have Major Detrimental Impact On Older People’s Movement And Independence, Study Indicates
Did You Know…
It is estimated that 20% of people age 55 years or older experience some type of mental health concern. The most common conditions include anxiety, severe cognitive impairment, and mood disorders (such as depression or bipolar disorder).
– American Association of Geriatric Psychiatry (2008)
